American Thoracic Society Documents an Official American Thoracic Society Clinical Practice Guideline: the Diagnosis of Intensive Care Unit–acquired Weakness in Adults on Behalf of the Ats Committee on Icu-acquired Weakness in Adults Overview Introduction Methods Guideline Panel Formulation of Quest
American Thoracic Society Documents an Official American Thoracic Society Clinical Practice Guideline: the Diagnosis of Intensive Care Unit–acquired Weakness in Adults on Behalf of the Ats Committee on Icu-acquired Weakness in Adults Overview Introduction Methods Guideline Panel Formulation of Quest
复制标题
DOI:
--
复制
发表时间:
--
期刊:
影响因子:
--
通讯作者:
E. Fan;Fern M. Cheek;L. Chlan;R. Gosselink;N. Hart;M. Herridge;R. Hopkins;C. Hough;J. Kress;N. Latronico;M. Moss;D. Needham;M. Rich;R. Stevens;K. Wilson;C. Winkelman;D. Zochodne;N. Ali
中科院分区:
文献类型:
--
作者:
E. Fan;Fern M. Cheek;L. Chlan;R. Gosselink;N. Hart;M. Herridge;R. Hopkins;C. Hough;J. Kress;N. Latronico;M. Moss;D. Needham;M. Rich;R. Stevens;K. Wilson;C. Winkelman;D. Zochodne;N. Ali
Rationale: Profound muscle weakness during and after critical illness is termed intensive care unit–acquired weakness (ICUAW). Objectives: To develop diagnostic recommendations for ICUAW. Measurement and Main Results: Severe sepsis, difficult ventilator liberation, and prolonged mechanical ventilation are associated with ICUAW. Physical rehabilitation improves outcomes in heterogeneous populations of ICU patients. Because it may not be feasible to provide universal physical rehabilitation, an alternative approach is to identify patients most likely to benefit. Patients with ICUAW may be such a group. Our review identified only one case series of patients with ICUAW who received physical therapy. When compared with a case series of patients with ICUAW who did not receive structured physical therapy, evidence suggested those who receive physical rehabilitation were more frequently discharged home rather than to a rehabilitative facility, although confidence intervals included no difference. Other interventions show promise, but fewer data proving patient benefit existed, thus precluding specific comment. Additionally, prior comorbidity was insufficiently defined to determine its influence on outcome, treatment response, or patient preferences for diagnostic efforts. We recommend controlled clinical trials in patients with ICUAW that compare physical rehabilitation with usual care and further research in understanding risk and patient preferences. Conclusions: Research that identifies treatments that benefit patients with ICUAW is necessary to determine whether the benefits of diagnostic testing for ICUAW outweigh its burdens. Overview Severe muscle weakness is common among critically ill patients, yet there is no consensus on whether or how to systematically identify patients with intensive care unit–acquired weakness (ICUAW). The guideline development committee began with a systematic review that identified that ICUAW may be more common among ICU patients with severe sepsis as well as those having difficulty being liberated from mechanical ventilation or requiring prolonged mechanical ventilation. Literature review failed to identify evidence comparing the effects of diagnostic testing versus no diagnostic testing on clinical outcomes. A small case series of patients with ICUAW who received physical therapy was identified, and when compared with a similar series of patients with ICUAW who did not receive physical therapy, it appeared that therapy patients might be discharged home rather than to a rehabilitative facility more frequently. However, the confidence intervals did not exclude no effect. As such, the evidence provides very little confidence in the estimated effects of physical therapy on clinical outcomes in patients with ICUAW. The guideline development committee is certain that additional research is necessary to determine …